+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

From
Kawasaki Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Kawasaki Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Laron Syndrome (LS) - Pipeline Insight, 2025 - Product Thumbnail Image

Laron Syndrome (LS) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Leigh Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Leigh Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lice Infestations - Pipeline Insight, 2025 - Product Thumbnail Image

Lice Infestations - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Danon Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Danon Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nail Diseases - Pipeline Insight, 2025 - Product Thumbnail Image

Nail Diseases - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Nerve Sheath Neoplasms - Pipeline Insight, 2025 - Product Thumbnail Image

Nerve Sheath Neoplasms - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Neurofibromatosis Type 2 - Pipeline Insight, 2025 - Product Thumbnail Image

Neurofibromatosis Type 2 - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Recurrent Pericarditis - Pipeline Insight, 2025 - Product Thumbnail Image

Recurrent Pericarditis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Antibody-Mediated Graft Rejection - Pipeline Insight, 2025 - Product Thumbnail Image

Antibody-Mediated Graft Rejection - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Ataxia Telangiectasia- Pipeline Insight, 2025 - Product Thumbnail Image

Ataxia Telangiectasia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Calciphylaxis - Pipeline Insight, 2025 - Product Thumbnail Image

Calciphylaxis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
CART-related Neurotoxicity (NT) - Pipeline Insight, 2025 - Product Thumbnail Image

CART-related Neurotoxicity (NT) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Sialorrhea - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Sialorrhea - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cocaine Intoxication - Pipeline Insight, 2025 - Product Thumbnail Image

Cocaine Intoxication - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cold Agglutinin Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Cold Agglutinin Disease- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Corneal Ulcer - Pipeline Insight, 2025 - Product Thumbnail Image

Corneal Ulcer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Coronary Occlusion (Includes CAD Also) - Pipeline Insight, 2025 - Product Thumbnail Image

Coronary Occlusion (Includes CAD Also) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Dry Eye Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Dry Eye Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more